Advertisement

The Histochemical Journal

, Volume 13, Issue 5, pp 793–797 | Cite as

The rationality and relative contribution of histochemical approaches to pharmacology and toxicology

  • E. D. Wachsmuth
Reviews and Papers

Conclusion

The contribution of histochemical investigations to pharmacology and toxicology has been questioned and the significance of results has been discussed in relation to the consumption of time and the expense of staff and equipment (Dayan, 1979). Without any doubt, one has to be cautious and critical when applying special histochemical techniques. However, there is a valuable place for the histochemical approach if one observes the following two precepts.
  1. (1)

    Histochemical techniques should only be used where the principal mechanism of action of a compound under investigation can be predicted and where they give more informative, specific and sensitive answers than routine histological methods

     
  2. (2)

    Histochemical and cytochemical methodology should be used only where other methods do not lead any further and where only special investigations in addition to routine toxicological investigations would give evidence about, and reasons for, the underlying pathological mechanisms.

     

In both cases, histochemical methodology should only be used for special types of toxicological investigations. In turn, the results observable with highly selective histochemical techniques allow us to understand minor and initially obscure staining patterns obtained in sections treated with routine, unselective stains such as Haematoxylin and Eosin and, thus, can broaden the scope for the microscopical detection of pharmacological and toxic effects during routine investigations.

Keywords

Toxic Effect Eosin Staining Pattern Special Investigation Haematoxylin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bannasch, P., Brenner, U., Hacker, H.-J., Klimek, F., Mayer, D., Moore, M. &Zerban, H. (1981) Cytochemical and biochemical microanalysis of carcinogenesis.Histochem. J. 13, 797–818.Google Scholar
  2. Borgers, M. (1981) The role of calcium in the toxicity of the myocardium.Histochem. J. 13, 839–48.Google Scholar
  3. Cochrane, C. G. &Koffler, D. (1973) Immune complex disease in experimental animals and man.Adv. Immunol. 16, 185–262.Google Scholar
  4. Davies, G. E. (1981) Toxicology of the immune system.Histochem. J. 13, 877–84.Google Scholar
  5. Dayan, A. D. (1979) A morphologist's approach to detection and study of neurotoxicity.Pharmacol. Ther. 5, 571–7.Google Scholar
  6. Eletreby, M. F. (1979) Practical applications of immunocytochemistry to the pharmacology and toxicology of the endocrine system.Histochem. J. 13, 819–36.Google Scholar
  7. Eränkö, O. (1978) Small intensely fluorescent (SIF) cells and nervous transmission in sympathetic ganglia.Ann. Rev. Pharmacol. Toxicol. 18, 417–30.Google Scholar
  8. Feuer, G., Goldberg, L. &Le Pelley, J. R. (1965) Liver response tests. I.Exploratory studies on glucose-6-phosphatase and other liver enzymes.Fd. Cosmet. Toxicol. 3, 235–49.Google Scholar
  9. Krinke, G. &Hess, R. (1981) The value of histochemistry of biogenic amines in the neurotoxicology.Histochem. J. 13, 847–62.Google Scholar
  10. Parillo, J. E. &Fauci, A. S. (1979) Mechanisms of glucocorticoid action on immune processes.Ann. Rev. Pharmacol. Toxicol. 19, 179–201.Google Scholar
  11. Stoward, P. J. (1980) Criteria for the validation of quantitative histochemical enzyme techniques. InTrends in Enzyme Histochemistry and Cytochemistry, Ciba Foundation Symposium, Vol. 73 (new series), pp. 11–31.Google Scholar
  12. Ten Veen, J. H. &Feltkamp-Vroom, T. M. (1973) Studies on drug induced lupus erythematosus in mice. III. Renal lesions and splenomegaly in drug-induced lupus erythematosus.Clin. exp. Immunol. 15, 591–600.Google Scholar
  13. Vanderlaan, M. &Phares, W. (1981).Gamma-glutamyl transpeptidase: a tumor cell marker with a pharmacological function.Histochem. J. 13, 863–76.Google Scholar
  14. Wachsmuth, E. D. (1980) Assessment of immunocytochemical techniques with particular reference to the mixed-aggregation immunocytochemical technique. InTrends in Enzyme Histochemistry and Cytochemistry, Ciba Foundation Symposium, Vol. 73 (new series), pp. 135–60.Google Scholar
  15. Wachsmuth, E. D. &Wirz, H.(1979) Relevance of enzyme evaluations in 24h urine to rat kidney injury caused by i.v. cephaloridine injection. InDiagnostic Significance of Enzymes and Proteins in Urine (edited byDubach U. C. andSchmidt, U.), pp. 88–104 Bern: Hans Huber.Google Scholar

Copyright information

© Chapman and Hall Ltd. 1981

Authors and Affiliations

  • E. D. Wachsmuth
    • 1
  1. 1.Research Department, Pharmaceuticals DivisionCiba-Geigy LtdBasleSwitzerland

Personalised recommendations